Kaushal Asrani

Research Associate


Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Kaushal Asrani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Find the latest version: Https://jci.me/128287/pdf mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT/TFE regulation

Asrani, K., Murali, S., Lam, B., Na, C. H., Phatak, P., Sood, A., Kaur, H., Khan, Z., Noë, M., Anchoori, R. K., Conover Talbot, C., Smith, B., Skaro, M. & Lotan, T. L., Dec 2 2019, In : Journal of Clinical Investigation. 129, 12, p. 5584-5599 16 p.

Research output: Contribution to journalArticle

Open Access
  • Immunolabeling of Cleared Human Pancreata Provides Insights into Three-Dimensional Pancreatic Anatomy and Pathology

    Noë, M., Rezaee, N., Asrani, K., Skaro, M., Groot, V. P., Wu, P. H., Olson, M. T., Hong, S. M., Kim, S. J., Weiss, M. J., Wolfgang, C., Makary, M. A., He, J., Cameron, J. L., Wirtz, D., Roberts, N., Offerhaus, G. J. A., Brosens, L. A. A., Wood, L. D. & Hruban, R. H., Jul 1 2018, In : American Journal of Pathology. 188, 7, p. 1530-1535 6 p.

    Research output: Contribution to journalArticle

  • MTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation

    Asrani, K., Sood, A., Torres, A., Georgess, D., Phatak, P., Kaur, H., Dubin, A., Talbot, C. C., Elhelu, L., Ewald, A., Xiao, B., Worley, P. F. & Lotan, T., Nov 1 2017, In : Journal of Clinical Investigation. 127, 11, p. 4001-4017 17 p.

    Research output: Contribution to journalArticle

  • The HER2- and heregulin b1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression

    Asrani, K., Keri, R. A., Galisteo, R., Brown, S. A. N., Morgan, S. J., Ghosh, A., Tran, N. L. & Winkles, J. A., Apr 1 2013, In : Molecular Cancer Research. 11, 4, p. 393-404 12 p.

    Research output: Contribution to journalArticle

  • The TWEAK receptor Fn14 is a therapeutic target in melanoma: Immunotoxins targeting Fn14 receptor for malignant melanoma treatment

    Zhou, H., Ekmekcioglu, S., Marks, J. W., Mohamedali, K. A., Asrani, K., Phillips, K. K., Brown, S. A. N., Cheng, E., Weiss, M. B., Hittelman, W. N., Tran, N. L., Yagita, H., Winkles, J. A. & Rosenblum, M. G., Apr 2013, In : Journal of Investigative Dermatology. 133, 4, p. 1052-1062 11 p.

    Research output: Contribution to journalArticle